Gamesys Group PLC Announces Carbon Trust certifies Gamesys carbon neutral
LONDON, UK / ACCESSWIRE / March 3, 2021 / Gamesys Group (LSE:GYS) has achieved carbon neutral…
LONDON, UK / ACCESSWIRE / March 3, 2021 / Gamesys Group (LSE:GYS) has achieved carbon neutral…
The Carbon Trust certifies Gamesys Group as carbon neutral LONDON, UK / ACCESSWIRE / March 3,…
LONDON, UK / ACCESSWIRE / March 3, 2021 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical…
STOCKHOLM, ZURICH and LONDON, UK / ACCESSWIRE / March 3, 2021 / In today’s world, strong…
VANCOUVER, BC / ACCESSWIRE / March 3, 2021 / Kingman Minerals Ltd. (TSX-V:KGS) (FSE:47A1) (“Kingman”…
LONDON, UK / ACCESSWIRE / March 3, 2021 / Dialog Semiconductor Plc (XETRA:DLG), a provider…
Underlying operating profit at US$110.5 million, up 21% year-on-year. Revenue excluding licensed PMICs was up…
ANN ARBOR, MI / ACCESSWIRE / March 2, 2021 / The Coretec Group, Inc. (OTCQB:CRTG), a…
MONTREAL, QC / ACCESSWIRE / March 2, 2021 / Hypertension is the medical term for high…
NEW YORK, NY / ACCESSWIRE / March 2, 2021 / Sonia Zarbatany is a world-renowned life…
Kranj, 3rd March 2021 – A public sale of unused radio frequencies could lead to…
NEWTON, Mass. and TEL AVIV, Israel, March 02, 2021 (GLOBE NEWSWIRE) — Hunters today announced…
Company announcement – No. 9 / 2021 Zealand Pharma Hosts Conference Call on March 11…
Pratteln, Switzerland, March 3, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces that the last patient has…
NEWS RELEASE – REGULATED INFORMATION 3 MARCH 2021, 07:00 A.M. CET Conference call with Q&A today…
Geneva, Switzerland and Boston, MA – March 3, 2021 – ObsEva SA (NASDAQ: OBSV /…
• The application includes robust data from the Phase 3 registration program, which demonstrated efficacy…
In 2020 the “Grindeks” Group has achieved the historically sharpest increase in turnover and profit In…
SINGAPORE, March 03, 2021 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage immunology focused…
WALTHAM, Mass., March 02, 2021 (GLOBE NEWSWIRE) — Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical…